Breaking News
April 25, 2019 - The Current issue of “The view from here” is concerned with Partnerships and Alliances
April 25, 2019 - Imaging method reveals long-lived patterns in cells of the eye
April 25, 2019 - Podcast: KHN’s ‘What The Health?’ The Abortion Wars Rage On
April 25, 2019 - Prolonged exposure therapy is more effective in treating veterans with PTSD, alcohol use disorder
April 24, 2019 - Our artificial cornea breakthrough could lead to self-assembling organs
April 24, 2019 - A Stanford black, female, gay surgery resident speaks out
April 24, 2019 - Donna Lynne on Extreme Sports, Lessons From the '60s, and Taking CUIMC to the Next Level
April 24, 2019 - Pain Clinics’ Doctors Needlessly Tested Hundreds Of Urine Samples, Court Records Show
April 24, 2019 - Researchers uncover potential clue to halt destruction of nerve cells in people with ALS
April 24, 2019 - Study uncovers reasons for poor mental health in bisexual people
April 24, 2019 - Screenings, interventions, and referrals can help adolescents overcome substance abuse
April 24, 2019 - Febrile seizures following vaccination are self-resolving and not dangerous
April 24, 2019 - Flow-UV inline UV-Visible spectrometer monitors dispersion in real time
April 24, 2019 - Rates of Marijuana Use in Cancer Patients on the Rise in U.S.
April 24, 2019 - Versatile drug may protect baby from hazards of intraamniotic infections
April 24, 2019 - Financial transparency may diminish trust in doctors, new study finds
April 24, 2019 - Calling all Riders: Velocity Extends Free Registration 
April 24, 2019 - The Homeless Are Dying In Record Numbers On The Streets Of L.A.
April 24, 2019 - Blocking BRAF ubiquitination may be an effective treatment approach in melanoma
April 24, 2019 - Simple mobility test helps predict hospital readmission in elderly heart attack patients
April 24, 2019 - Novel fluorescence imaging system helps surgeons remove small ovarian tumors
April 24, 2019 - Uncovering the Structure of HIV Integrase to Inform Drug Discovery
April 24, 2019 - Medical Marijuana Use Rising Among Cancer Patients
April 24, 2019 - Artificial intelligence approach optimizes embryo selection for IVF
April 24, 2019 - Doctor or detective? Sleuthing mysteries in medical school
April 24, 2019 - CUIMC Community Gives Blood During Spring 2019 Columbia University Blood Drive
April 24, 2019 - Americans Overwhelmingly Want Federal Protections Against Surprise Medical Bills
April 24, 2019 - Making Laboratories More Efficient with the Most Modern LIMS on the Market
April 24, 2019 - Treating cancer patients with personalized, combination therapies improves outcomes
April 24, 2019 - Researchers engineer new molecules to help stop lung cancer
April 24, 2019 - Acupuncture can be a wonderful tool for preventing number of diseases
April 24, 2019 - Daily life disability before hip replacement may predict poor post-operative outcomes
April 24, 2019 - Study finds involuntary staying in housing estates to be a potential health risk
April 24, 2019 - Older kidney disease patients starting dialysis die at higher rates than previously thought
April 24, 2019 - Time-restricted eating shows promise for controlling blood glucose levels
April 24, 2019 - Ambiguous genitalia in newborns may be more common than previously thought
April 24, 2019 - Research provides important insight on the brain-body connection
April 24, 2019 - In 10 Years, Half Of Middle-Income Elders Won’t Be Able To Afford Housing, Medical Care
April 24, 2019 - Researchers study how E. coli clones have become major cause of drug-resistant infections
April 24, 2019 - Bacterial and fungal toxins found in popular electronic cigarettes
April 24, 2019 - Factors affecting absorption of ‘sunshine vitamin’ during spring/summer months
April 24, 2019 - Texting helps improve medication adherence, health outcomes for patients with schizophrenia
April 24, 2019 - Cochrane Review looks at different ways to use nicotine replacement therapies
April 24, 2019 - New review on relationship between COPD and Type 2 diabetes
April 24, 2019 - Brain areas linked to memory and emotion aid odor navigation in humans
April 24, 2019 - Brain stimulation reverses age-related memory loss
April 24, 2019 - Amid Opioid Prescriber Crackdown, Health Officials Reach Out To Pain Patients
April 24, 2019 - $4 million NIH award will help establish UCI Skin Biology Resource-based Center
April 24, 2019 - Cancer drugs reprogram genes in breast tumors to prevent endocrine resistance, finds study
April 24, 2019 - Combination-imaging technique provides new window into macaque brain connections
April 24, 2019 - Researchers identify new allergen responsible for allergy to durum wheat
April 24, 2019 - Researchers define role of rare, influential cells in the bone marrow
April 24, 2019 - DNA rearrangement may predict poor outcomes in multiple myeloma
April 24, 2019 - FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis
April 24, 2019 - Combination therapy might be beneficial in schizophrenia
April 24, 2019 - Blood test can help match cancer patients to early phase clinical trials
April 24, 2019 - Women tend to underreport snoring and underestimate its loudness
April 24, 2019 - Comprehensive molecular test introduced for diagnosis of malaria caused by P. vivax parasites
April 24, 2019 - New range prediction approach increases accuracy, safety and tolerability of proton therapy
April 24, 2019 - Need for Sedation Up for Regular Cannabis Users
April 24, 2019 - Lack of access to antibiotics is a major global health challenge
April 24, 2019 - New study provides better understanding on safety of deworming programs
April 24, 2019 - EEG used to detect impact of maternal stress on neurodevelopment in 2-month-old infants
April 24, 2019 - FDA Approves First Generic Naloxone Nasal Spray Against Opioid Overdose
April 24, 2019 - A new way of finding compounds that prevent aging
April 24, 2019 - Mechanical training makes synthetic hydrogels perform more like muscle
April 24, 2019 - Study provides new insights into regulatory T cells’ role in protecting against autoimmune disease
April 24, 2019 - Pregnant women with type 1 diabetes are at greater risk of preterm birth
April 24, 2019 - ‘Tummy tuck’ can be safely performed in obese patients with no increase in complications
April 23, 2019 - ‘First’ 3-D print of heart with human tissue, vessels unveiled
April 23, 2019 - Which blood-based method works best to detect TB?
April 23, 2019 - Gene therapy cures infants suffering from ‘bubble boy’ immune disease
April 23, 2019 - Chemical-sampling wristbands detect similar exposures across three continents
April 23, 2019 - Management of Residual Limb Pain
April 23, 2019 - Molecular clock influences immune cell responses
April 23, 2019 - On the importance of culture, partnerships and diversity at the Dean’s Lecture Series
April 23, 2019 - Siddhartha Mukherjee Receives Lewis Thomas Prize for Writing About Science
April 23, 2019 - Dengue mosquito poses greatest danger of spreading Zika virus in Australia
April 23, 2019 - Scientists identify 104 high-risk genes for schizophrenia
April 23, 2019 - Abdominal etching can help patients to get classic ‘six-pack abs’ physique
Researchers to study the use of CRISPR on human liver on-a-chip platform

Researchers to study the use of CRISPR on human liver on-a-chip platform

image_pdfDownload PDFimage_print

Two Arizona State University professors are among the first recipients of Somatic Cell Genome Editing (SCGE) grants from the National Institutes of Health Common Fund. The $2,600,000, five-year grant will fund the first study of the genome editing technology CRISPR to be used on a “human liver on-a-chip” platform.

The SCGE program, launched in January 2018, is aimed at improving therapeutic options for both rare and common diseases, including supporting methods to improve editing the human genome.

Samira Kiani and Mo Ebrahimkhani, assistant professors in the School of Biological and Health Systems Engineering, are combining their expertise in Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR, technology and human microphysiological systems to assess the safety and efficacy of genome editing and its effects on human tissue function.

CRISPR enables researchers to target genes and genetic materials in cells to regulate how they behave and function. Because of CRISPR’s ease of engineering and programmability, it is considered a breakthrough technology with the potential to help cure disease, repair damaged body tissue and in other ways restore people’s health.

However, as with any new technology, applying the CRISPR method can potentially produce some unintended results.

“[CRISPR] is a pathogenic source, so to put this in humans, you face a number of concerns, such as toxicity, an immune response, or some other side effects that it might affect cell tissues in humans,” says Kiani, the project lead for the multi-institution endeavor. “There’s a chance introducing the system creates some sort of off-target effects in the genome, meaning that it not only influences the target DNA code, but also does some unintended modifications in parts of the genome that we don’t know [about] and don’t want.”

Kiani and Ebrahimkhani will apply the CRISPR method on the Liverchip® platform in an effort to identify the biomarkers within the human liver genome that indicate toxicity. DNA analysis will also reveal biomarkers that indicate the off-target effects of Cas9 – the DNA-cleaving enzyme used in CRISPR that enables highly precise gene editing and regulation.

Until now, CRISPR has only been tested in animal models or human cell lines. Using the Liverchip® platform provides a model that recapitulates closely human biology and will significantly reduce the number of discrepancies introduced by animal models.

These organ-on-a-chip mediums are essentially a 3D cell culture system designed to have the specific features that would exist in a human body. Multiple cells within the medium self-assemble to generate a tissue similar to a human organ, even mimicking the human body’s blood flow and the profusion of the media in cells.

“The final objective is to create a culture system that can predict the liver tissue response in humans,” says Ebrahimkhani, who worked with this platform during his studies at Massachusetts Institute of Technology. “In the long term, we hope to be able to achieve a candidate CRISPR system that can target a specific gene in humans with control over cell type, time of action and any potential toxicity.”

The liver is likely to be one of the first human organs where gene therapies will be tested. Given the frequency of degenerative, genetic diseases associated with metabolism and the function of the liver, using the liver-on-a-chip platform as a proxy for human liver cells is ideal for studying CRISPR/Cas9’s effectiveness as a therapeutic tool.

The multidisciplinary team of investigators includes Jin Park, an assistant research professor in the Virginia G. Piper Center for Personalized Diagnostics at ASU’s Biodesign Institute. Park will help with data analysis of the RNA and DNA sequences to identify biomarkers in tissues. Linda Griffith, the School of Engineering Teaching Innovation Professor of Biological and Mechanical Engineering at the Massachusetts Institute of Technology and a leading expert in microphysical systems, and David Hughes of CN Bio Innovations – the commercial vendor for the Liverchip®- are collaborating with the ASU team in this research. They will contribute novel technologies and their expertise relevant to human-based cellular platforms.

“We’re excited this opportunity to see that NIH entrusted the leadership of this multi-institution grant to Samira and Mo,” says Marco Santello, director of the School of Biological and Health Systems Engineering, one of the six schools in the Ira A. Fulton Schools of Engineering. “It’s a true testament to the caliber of the faculty in the Fulton Schools.”

Tagged with:

About author

Related Articles